Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults
Clinical trial NCT04213105 · UNKNOWN
Trial details
- NCT number
- NCT04213105
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-31
- Primary completion
- 2020-10-31
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.